Xenetic Biosciences Inc (XBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,960 | -4,135 | -6,552 | -5,645 | -10,894 |
| Depreciation Amortization | N/A | N/A | 27 | 36 | 29 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -2,919 |
| Other Working Capital | 971 | -263 | -427 | 461 | -52 |
| Other Operating Activity | 172 | 283 | 2,305 | 410 | 9,568 |
| Operating Cash Flow | $-2,818 | $-4,114 | $-4,647 | $-4,738 | $-4,267 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | N/A | -500 | N/A | N/A |
| Investing Cash Flow | $N/A | $N/A | $-500 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 11,455 | 5,427 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $11,455 | $5,427 |
| Beginning Cash Position | 8,983 | 13,097 | 18,244 | 11,528 | 10,368 |
| End Cash Position | 6,166 | 8,983 | 13,097 | 18,244 | 11,528 |
| Net Cash Flow | $-2,818 | $-4,114 | $-5,147 | $6,717 | $1,160 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,818 | -4,114 | -4,647 | -4,738 | -4,267 |
| Free Cash Flow | -2,818 | -4,114 | -4,647 | -4,738 | -4,267 |